- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy”.No. Publication Date Citing Article 1 2023 Deepti Sharma, Abi M. Thomas, George Koshy. Tumor Infiltrating Lymphocytes as Immunebiomarkers in Oral Cancer: An Update, Journal of Cancer Research Updates. 2023; 12: 33. https://doi.org/10.30683/1929-2279.2023.12.6 2 2022 Siddhartha Dutta, Shubha Singhal, Rima B. Shah, Mainul Haque. Immunotherapy and Targeted Therapy in the Management of Oral Cancers , Critical Reviews™ in Oncogenesis. 2022; 27: 23. https://doi.org/10.1615/CritRevOncog.2022046361 3 2024 Johanna Kirchner, Ioana Plesca, Rebecca Rothe, Antonia Resag, Steffen Löck, Iva Benešová, Luise Rupp, Annett Linge, Rebekka Wehner, Mechthild Krause, Marc Schmitz. Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients, Frontiers in Immunology. 2024; 15: 1414298. https://doi.org/10.3389/fimmu.2024.1414298 -
